Directors Dealings
Director dealings are proprietary transactions by executives, which are reportable under Art. 19 MAR. The publication of these transactions is an important contribution to the prevention of insider dealing and market manipulation. In addition, knowledge of such transactions is of great importance to the market, as these transactions provide indications of management's assessment of the company's future business prospects. The information presented here relates to companies that are under the supervision of BaFin.
ENCAVIS AG: A reportable insider transaction was published on 28th September 2023. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 28th September 2023,
The Insider Transaction was made by Krüper, Dr. Manfred 
. The transaction toke place on 27th September 2023. The order was executed at the trading place XETRA. . The aggregated volume was 19.200,00 EUR, based on an average price of 12,80 EUR. The nature of the Investment was Buy.
ENCAVIS AG: A reportable insider transaction was published on 16th August 2023. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 16th August 2023,
The Insider Transaction was made by Krüper, Dr. Manfred . The transaction toke place on 15th August 2023. The order was executed at the trading place XETRA. . The aggregated volume was 40.500,00 EUR, based on an average price of 13,50 EUR. The nature of the Investment was Buy.
ENCAVIS AG: A reportable insider transaction was published on 2nd June 2023. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 2nd June 2023,
The Insider Transaction was made by Krüper, Dr. Manfred . The transaction toke place on 31st May 2023. The order was executed at the trading place XETRA. . The aggregated volume was 21.000,00 EUR, based on an average price of 15,00 EUR. The nature of the Investment was Buy.
ENCAVIS AG: A reportable insider transaction was published on 19th January 2023. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 19th January 2023,
The Insider Transaction was made by Krüper, Dr. Manfred . The transaction toke place on 19th January 2023. The order was executed at the trading place XETRA. . The aggregated volume was 100.740,00 EUR, based on an average price of 16,79 EUR. The nature of the Investment was Buy.
ENCAVIS AG: A reportable insider transaction was published on 6th July 2022. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 6th July 2022,
The Insider Transaction was made by Krüper, Dr. Manfred . The transaction toke place on 5th July 2022. The order was executed at the trading place XETRA. . The aggregated volume was 36.108,75 EUR, based on an average price of 18,05 EUR. The nature of the Investment was Buy.
Disclaimer:
The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster.
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.
If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.